122 related articles for article (PubMed ID: 2033252)
1. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors.
Sidell N; Taga T; Hirano T; Kishimoto T; Saxon A
J Immunol; 1991 Jun; 146(11):3809-14. PubMed ID: 2033252
[TBL] [Abstract][Full Text] [Related]
2. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
[TBL] [Abstract][Full Text] [Related]
3. Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.
Schwabe M; Brini AT; Bosco MC; Rubboli F; Egawa M; Zhao J; Princler GL; Kung HF
J Clin Invest; 1994 Dec; 94(6):2317-25. PubMed ID: 7989587
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
5. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines.
Lasfar A; Wietzerbin J; Billard C
Eur J Immunol; 1994 Jan; 24(1):124-30. PubMed ID: 8020547
[TBL] [Abstract][Full Text] [Related]
7. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
9. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells.
Keller ET; Ershler WB
J Immunol; 1995 Apr; 154(8):4091-8. PubMed ID: 7706747
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone plus retinoids decrease IL-6/IL-6 receptor and induce apoptosis in myeloma cells.
Smith MR; Xie T; Joshi I; Schilder RJ
Br J Haematol; 1998 Sep; 102(4):1090-7. PubMed ID: 9734662
[TBL] [Abstract][Full Text] [Related]
11. [Interleukin 6 receptors on human bronchial epithelial cells].
Takizawa H; Ito K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():77-81. PubMed ID: 1306242
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H
Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts.
Zitnik RJ; Kotloff RM; Latifpour J; Zheng T; Whiting NL; Schwalb J; Elias JA
J Immunol; 1994 Feb; 152(3):1419-27. PubMed ID: 8301142
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of expression of interleukin-6 and its receptor results in growth inhibition of MCF-7 breast cancer cells.
Jiang XP; Yang DC; Elliott RL; Head JF
Anticancer Res; 2011 Sep; 31(9):2899-906. PubMed ID: 21868536
[TBL] [Abstract][Full Text] [Related]
16. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis.
Levy Y; Labaume S; Colombel M; Brouet JC
Clin Exp Immunol; 1996 Apr; 104(1):167-72. PubMed ID: 8603522
[TBL] [Abstract][Full Text] [Related]
18. Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop.
Jernberg-Wiklund H; Pettersson M; Carlsson M; Nilsson K
Leukemia; 1992 Apr; 6(4):310-8. PubMed ID: 1588793
[TBL] [Abstract][Full Text] [Related]
19. Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo.
Suzuki H; Yasukawa K; Saito T; Goitsuka R; Hasegawa A; Ohsugi Y; Taga T; Kishimoto T
Eur J Immunol; 1992 Aug; 22(8):1989-93. PubMed ID: 1639101
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin M.
Silvani A; Ferrari G; Paonessa G; Toniatti C; Parmiani G; Colombo MP
Cancer Res; 1995 May; 55(10):2200-5. PubMed ID: 7743524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]